Target
Transient receptor potential cation channel subfamily A member 1
Ligand
BDBM481828
Substrate
n/a
Meas. Tech.
FLIPR Assay
IC50
59.7±n/a nM
Citation
 Chen, HShore, DVillemure, EVolgraf, MHu, BLu, ACridland, AWard, SBeaumier, FDery, MLarouche-Gauthier, R Oxadiazolones as transient receptor potential channel inhibitors US Patent  US10913742 Publication Date 2/9/2021 
Target
Name:
Transient receptor potential cation channel subfamily A member 1
Synonyms:
ANKTM1 | Ankyrin-like with transmembrane domains protein 1 | TRPA1 | TRPA1_HUMAN | Transformation-sensitive protein p120 | Transient receptor potential cation channel subfamily A member 1 (TRPA1)
Type:
Protein
Mol. Mass.:
127514.20
Organism:
Homo sapiens (Human)
Description:
O75762
Residue:
1119
Sequence:
MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIAEVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEP
  
Inhibitor
Name:
BDBM481828
Synonyms:
4-[3-[5-[(7-methyl-6-oxo-purin- 1-yl)methyl]-2-oxo-1,3,4- oxadiazol-3- yl]cyclobutyl]benzonitrile | US10913742, Example 71
Type:
Small organic molecule
Emp. Form.:
C20H17N7O3
Mol. Mass.:
403.3941
SMILES:
Cn1cnc2ncn(Cc3nn([C@H]4C[C@@H](C4)c4ccc(cc4)C#N)c(=O)o3)c(=O)c12 |r,wU:14.16,wD:12.11,(-10.3,-2.41,;-9.83,-.95,;-10.73,.3,;-9.83,1.54,;-8.36,1.07,;-7.03,1.84,;-5.69,1.07,;-5.69,-.47,;-4.36,-1.24,;-3.03,-.47,;-1.62,-1.1,;-.59,.04,;.94,-.12,;1.87,-1.34,;3.1,-.41,;2.17,.81,;4.63,-.62,;5.21,-2.05,;6.74,-2.25,;7.68,-1.04,;7.1,.39,;5.57,.6,;9.2,-1.25,;10.73,-1.45,;-1.36,1.38,;-.73,2.78,;-2.86,1.06,;-7.03,-1.24,;-7.03,-2.78,;-8.36,-.47,)|
Structure:
Search PDB for entries with ligand similarity: